Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474496 · ClinicalTrials.gov registry record
Impact of COVID-19 on Marshallese Communities in the U.S.
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 120
- Enrollment target
NCT04474496 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 120 participants.
The verdict
NCT04474496 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Marshallese adults in the U.S. will complete an online or telephone survey. This survey will collect data describing the impact of COVID-19 on Marshallese communities. Data collected will help describe: 1) risk exposure, 2) knowledge of preventive recommendations, 3) barriers and facilitators to implementing preventative recommendations, 4) barriers and facilitators to COVID-19 testing when appropriate, and 5) self-care behaviors during COVID-19. Participant inclusion criteria: 1) Self-reported Marshallese; 2) 18 years of age or older; 3) Live in the Continental U.S. or Hawaii.
Interventions
- OTHER Assessing the impact of COVID-19
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2020-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474496
The ClinicalTrials.gov registry entry for NCT04474496 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Assessing the impact of COVID-19 is the first listed.
NCT04474496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04474496 about?
NCT04474496 is a clinical study titled "Impact of COVID-19 on Marshallese Communities in the U.S.". Marshallese adults in the U.S. will complete an online or telephone survey. This survey will collect data describing the impact of COVID-19 on Marshallese communities. Data collected will help describe: 1) risk exposure, 2) knowledge of preventive recommendations, 3) barriers and facilitators to imp...
What is the current status of trial NCT04474496?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2020-07-27. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT04474496?
The interventions under investigation include: Assessing the impact of COVID-19 (OTHER).
Who is sponsoring clinical trial NCT04474496?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.